The linear and cyclic structures create different chemical identities and can produce different experimental behavior. A paper's exact sequence must therefore match the reference selected for a comparison. Melanotan 1 peptide terminology should not be shortened to melanotan when that would erase the distinction. Keep the full name through receipt and analysis.
Representative product imagery. Verify the physical label and lot documentation on receipt.
Metabolic Research
Melanotan 1
In stock·Ships in 1–2 business days
Melanotan 1 peptide supplied in a 10 mg research vial. Each unit is labeled with a traceable lot code and links to its corresponding analytical report.
Select size1 option
Select pack sizeSave 18% on kits
1 × 10 mg$41.99
In stockSelected size 10 mgSC-MT1-010
Transparent volume pricing10-vial peptide kits save 18%.
Secure checkout US & EU dispatch
Research use only acknowledgment required at checkout
Report not published
Compound context
What researchers study
Melanotan 1 is a synthetic melanocortin analog investigated in receptor and peptide research. It differs structurally from melanotan 2, so the number is part of the material identity. This listing is for laboratory use with available quantities shown in the selector. It is not supplied as a tanning product or a personal administration program.
Melanocortin receptors are distinct targets within a broader biological system. A reference may be examined for binding or for a downstream signaling response, and those measurements are not identical. Literature about an approved afamelanotide formulation also needs to be kept separate from this research vial. A related active molecule does not establish product equivalence.
A selectivity comparison should state which receptor subtypes were tested and how the response was measured. Apparent potency can vary with receptor expression and assay conditions. Structural differences between the linear analog and a cyclic sequence cannot be ignored when comparing results. Equal mass does not create an equal or interchangeable biological exposure.
Scope limitConfirm the sequence and material form against the current lot report. Research use excludes cosmetic administration or a human tanning schedule. A purity measurement cannot establish clinical safety or equivalence to an approved medicine.
Serenity Compounds is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act.
Common laboratory focus
Selectivity describes measured differences across specified targets. It doesn't prove that every possible effect has been excluded. Reference ligands and consistent conditions help define the comparison. A cell based result remains a finding in that system and does not by itself establish a cosmetic outcome or a safe route of administration.
Evidence for a medicine applies to its evaluated formulation and indication. A catalog material with a related name has not automatically undergone that evaluation. Preserve the product category when interpreting a clinical publication. The useful research question concerns identity and assay suitability rather than borrowing a drug product's approval or benefits.
Quality documentation
Know what your laboratory receives.
Batch records are published for transparency and should be independently reviewed by qualified research personnel.
Current certificateMelanotan 1 · Report not publishedSee original reportView report
- Tamper-evident packaging
- Lot and SKU traceability
- Independent analytical review
Continue exploring
